SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-18-000469
Filing Date
2018-12-03
Accepted
2018-12-03 14:18:34
Documents
4
Period of Report
2018-11-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnbt120318form8k.htm 8-K 27555
2 EXHIBIT 4.1 ex4_1.htm EX-4.1 239450
3 EXHIBIT 4.2 ex4_2.htm EX-4.2 47811
4 EXHIBIT 10.1 ex10_1.htm EX-10.1 43587
  Complete submission text file 0001607062-18-000469.txt   359624
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-25169 | Film No.: 181213706
SIC: 2834 Pharmaceutical Preparations